Disclaimer

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions



DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?

SJM-CV WEB-0718-0009

/content/bss/divisionalsites/livesites/reusable/cv-livesite/us/en/pages/home
30
CARDIOVASCULAR
hamburger
BACK
CARDIOMEMS HF SYSTEM
Patient Selection

Patient Selection & Assessment

Selecting the Right Patient

The CardioMEMS™ HF System is indicated for patients with:¹

  • NYHA Class III heart failure; and
  • One heart failure hospitalization in the past 12 months.

The CardioMEMS HF System is contraindicated for patients with:

  • An inability to take dual antiplatelet or anticoagulants for one-month post implant

Patients who most commonly receive the CardioMEMS HF System are those on GDMT and those who exhibit any of the following:¹

  • Fluid volumes that are hard to know or manage
  • Challenging physical assessment
  • Is a patient with HFpEF or HFrEF
  • Compliant with heart failure medical care
  • Would benefit from remote monitoring if they live far from a clinic

Note: The CHAMPION trial specifically excluded patients with American College of Cardiology/ American Heart Association stage D heart failure who needed advanced therapies (i.e., left ventricular assist device, transplant or inotropic support). Even if inotropic support improved heart failure symptoms, a patient would still be defined as stage D, with refractory heart failure.¹

Stages of Heart Failure

Patient Selection Resources

Patient Identification Tool

This document provides information to help you understand which of your HF patients would be good candidates for the CardioMEMS HF System.

CardioMEMS HF System Patient Approach with Philip B. Adamson, MD, MSC, FACC (06:01)

In this video, Philip B. Adamson, M.D., MSc, FACC, reviews essential tips for approaching patients about their symptoms and engaging in conversation about the CardioMEMS HF System.

CardioMEMS HF System Patient Approach with Jamie Pelzel, MD (07:43)

In this video, Jamie Pelzel, MD, reviews essential tips to approaching patients about their symptoms and engaging in conversation about the CardioMEMS HF System.

CardioMEMS HF System Patient Approach with Stephanie Preister, CNP (05:46)

In this video, Stephanie Preister, CNP, leads a discussion with patients about the CardioMEMS HF System and patient compliance.

This device is commercially available for use in select international markets.

References

  1. Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M., Costanzo, M. R., Stevenson, L. W., …Yadav, J. S., for the CHAMPION Trial Study Group. (2011). Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. The Lancet, 377(9766), 658-666. https://dx.doi.org/10.1016/S0140-6736(11)60101-3
INDICATIONS, SAFETY & WARNINGS

MAT-2116103 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

YESNO
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

The following content is intended for Healthcare Professionals except for those in France. Some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.



Si vous êtes un professionnel de santé exerçant en France ou dans les territoires Français, veuillez visiter notre site en français.



Do you want to continue? 

YesNo